RVL Pharmaceuticals plc Annual Interest Expense in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
RVL Pharmaceuticals plc quarterly/annual Interest Expense history and growth rate from 2017 to 2022.
  • RVL Pharmaceuticals plc Interest Expense for the quarter ending June 30, 2023 was $13K, a 98.7% decline year-over-year.
  • RVL Pharmaceuticals plc Interest Expense for the twelve months ending June 30, 2023 was $1.19M, a 70.2% decline year-over-year.
  • RVL Pharmaceuticals plc annual Interest Expense for 2022 was $3.11M, a 2.44% increase from 2021.
  • RVL Pharmaceuticals plc annual Interest Expense for 2021 was $3.04M, a 25.9% decline from 2020.
  • RVL Pharmaceuticals plc annual Interest Expense for 2020 was $4.1M, a 31.9% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.11M +$74K +2.44% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-20
2021 $3.04M -$1.06M -25.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $4.1M -$1.92M -31.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $6.01M -$14.8M -71.1% Jan 1, 2019 Dec 31, 2019 8-K 2021-09-08
2018 $20.8M -$8.26M -28.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 $29.1M Jan 1, 2017 Dec 31, 2017 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.